© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Tofacitinib Citrate usually appears as an off-white to yellowish solid. You notice a crystalline form that ranges from fine powder to granular flakes, often with a pearl-like sheen when spread out under direct light. In terms of chemical identity, the molecular formula is C16H20N6O·C6H8O7. The structure reveals a pyrrolo[2,3-d]pyrimidine skeleton—this core connects with various aromatic and heterocyclic rings, allowing interactions that block specific Janus kinase enzymes. This is a pharmaceutical intermediate, not a regular commodity, and its HS Code for customs purposes often reads 2934999099, which places it among heterocyclic compounds with nitrogen hetero-atoms.
You measure a specific density near 1.53 g/cm³, which means the solid is compact and doesn't puff up like some fibrous materials. Tofacitinib Citrate does not act as a volatile compound, and it does not release noticeable vapors at room temperature. Its appearance as powder, flakes, or tiny crystals depends on preparation technique, but the substance resists caking and does not clump if handled with dry, clean processes. In a laboratory or factory setting, this material dissolves in DMSO and ethanol but shows limited solubility in water or non-polar organics, which matters if you're formulating dosage forms or cleaning spills.
Handling raw Tofacitinib Citrate means working with its solid crystalline form, not a pre-made solution or blended mix. As a raw material, it stands as a stable solid when kept away from moist environments and direct heat. Heat above 230°C brings risk of decomposition, where the breakdown can produce nitrogen oxides and toxic fumes—the kind that force a factory to trigger its incident alarms. In professional usage, the raw form serves as an API (active pharmaceutical ingredient) intermediate. Feedstock always comes with supporting data on purity and residual solvents, as impurities not only alter particle properties but also impact regulatory compliance.
There’s no ignoring the risks with any potent small-molecule kinase inhibitor. Tofacitinib Citrate carries warnings on toxicity if inhaled, swallowed, or absorbed through the skin. Direct skin contact should be avoided. Extended exposure, even small spills left on a bench, could lead to headaches, mild nausea, and possible allergic response—on the severe end, accidental ingestion leads to far more than an upset stomach. Data sheets from multiple manufacturers flag this as potentially hazardous to aquatic life, so runoff into drains cannot happen. Here, E-E-A-T principles matter: only those trained in pharma or chemical safety ought to touch this, and never without gloves, eye protection, and mask when working with dusty forms.
Chemists recognize Tofacitinib Citrate for use in labs redefining autoimmune disease therapies and inflammation management, but the handling never happens outside controlled environments. Labs rely on closed systems or laminar-flow hoods to limit airborne particles. Waste material ends up in specialized hazardous bins—no tossing leftovers down the ordinary trash chute. Traceability remains a core principle—batch numbers, supplier certificates, and purity analysis all document a clear provenance chain, protecting workers and downstream patients. Whenever I’ve been involved in raw API processing, every spill triggers a full clean-down, never ignored, because trace amounts can cause harm if they build up.
With a molecular weight close to 504.47 g/mol, the compound’s structure showcases fused rings critical for selective inhibition activity. The citrate portion serves dual purposes, not only adjusting solubility and stability but also providing a counterion recognized as safe (GRAS) for drug salt formation. Solid-state impurities or changes like hydration shift the density and firmness—a reminder that storing open vials or using unverified suppliers jeopardizes quality. Reliable NMR, IR, and mass spec profiles allow rapid confirmation of identity, and any deviation in melting point or visual form signals a quality issue that warrants investigation.
Good lab and manufacturing practice will always separate hazardous substances from less risky ingredients. I’ve seen teams lose weeks of work because a single spill contaminated a shared workspace, forcing every other project to halt. Long sleeves, powder-resistant gloves, N95 or better masks, and splash goggles become your daily companions with materials like this. Companies that invest in detailed training, solid local exhaust ventilation, and rigorous waste disposal reduce incidents, protect employees, and keep environmental regulators satisfied. Whatever savings you may imagine by cutting corners never stand up to the costs of contamination or poisoning. Institutions can add extra safety by color-coding containers, enforcing batch log-ins, and continuous refresher training for staff handling these raw chemicals.
The value of Tofacitinib Citrate lies not only in its pharmaceutical impact but also in the lessons it teaches around chemical stewardship. At every production step, science supports the practice—verified purity, excessive checks, no shortcuts. The basic message comes clear from experience: trust in systematic, cautious handling, documented storage, and prompt cleanup wraps around every decision, because safety slips come back to haunt you and your colleagues long after a day’s work is done.
